These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12537701)

  • 41. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area.
    Shields LB; Hunsaker Iii JC; Corey TS; Ward MK; Stewart D
    J Forensic Sci; 2007 Nov; 52(6):1389-95. PubMed ID: 18093068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
    Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
    Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methadone and impairment in apprehended drivers.
    Bernard JP; Mørland J; Krogh M; Khiabani HZ
    Addiction; 2009 Mar; 104(3):457-64. PubMed ID: 19207356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-mortem drug concentrations.
    Kennedy MC
    Intern Med J; 2010 Mar; 40(3):183-7. PubMed ID: 19849743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.
    Gibson AE; Degenhardt LJ
    Drug Alcohol Rev; 2007 Jul; 26(4):405-10. PubMed ID: 17564876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-mortem clinical pharmacology.
    Ferner RE
    Br J Clin Pharmacol; 2008 Oct; 66(4):430-43. PubMed ID: 18637886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered dose incentive procedures: effects on polydrug use among methadone maintenance patients.
    Stitzer ML; Bickel WK; Bigelow GE
    NIDA Res Monogr; 1987; 76():162-7. PubMed ID: 3125444
    [No Abstract]   [Full Text] [Related]  

  • 53. Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.
    Hiltunen AJ; Beck O; Hjemdahl P; Liljeberg P; Almström U; Brodin K; von Wachenfeldt J; Borg S
    Psychopharmacology (Berl); 1999 Apr; 143(4):385-93. PubMed ID: 10367556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of stress on craving for methadone depends on the timing of last methadone dose.
    Ilgen M; Jain A; Kim HM; Trafton JA
    Behav Res Ther; 2008 Oct; 46(10):1170-5. PubMed ID: 18675399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methadone-related fatalities: review in the Ghent district between 1978-2008.
    Van Den Broecke SM; De Letter EA; Lambert WE; Verstraete AG; Piette MH
    Acta Clin Belg; 2012; 67(5):352-61. PubMed ID: 23189543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methadone maintenance: plasma levels and therapeutic outcome.
    Holmstrand J; Anggård E; Gunne LM
    Clin Pharmacol Ther; 1978 Feb; 23(2):175-80. PubMed ID: 620477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steady-state pharmacokinetics of methadone maintenance patients: renal clearance in low vs high dosages.
    Bellward GD
    Proc West Pharmacol Soc; 1977; 20():483-5. PubMed ID: 19769
    [No Abstract]   [Full Text] [Related]  

  • 58. The levels of methadone in the plasma in methadone maintenance.
    Inturrisi CE; Verebely K
    Clin Pharmacol Ther; 1972; 13(5):633-7. PubMed ID: 5053808
    [No Abstract]   [Full Text] [Related]  

  • 59. [Fatal cases of methadone].
    Ege PP
    Ugeskr Laeger; 1998 Apr; 160(17):2558-9. PubMed ID: 9599542
    [No Abstract]   [Full Text] [Related]  

  • 60. [Bruise-like discolorations can appear after death].
    Terazawa K; Okumura M
    Hokkaido Igaku Zasshi; 2000 Jan; 75(1):53-8. PubMed ID: 10736761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.